Weimin Hong

990 total citations
24 papers, 785 citations indexed

About

Weimin Hong is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Weimin Hong has authored 24 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in Weimin Hong's work include Receptor Mechanisms and Signaling (17 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Neuroscience and Neuropharmacology Research (10 papers). Weimin Hong is often cited by papers focused on Receptor Mechanisms and Signaling (17 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Neuroscience and Neuropharmacology Research (10 papers). Weimin Hong collaborates with scholars based in United States, China and Poland. Weimin Hong's co-authors include Susan Amara, Jonathan L. Katz, Linda L. Werling, Takato Hiranita, Tsung‐Ping Su, Hideaki Yano, Maarten E. A. Reith, Kyle C. Schmitt, Bruce E. Blough and Kymry T. Jones and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Weimin Hong

21 papers receiving 782 citations

Peers

Countries citing papers authored by Weimin Hong

Since Specialization

Citations

This map shows the geographic impact of Weimin Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Hong more than expected).

Fields of papers citing papers by Weimin Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weimin Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Hong. The network helps show where Weimin Hong may publish in the future.

Co-authorship network of co-authors of Weimin Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Weimin Hong. A scholar is included among the top collaborators of Weimin Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weimin Hong. Weimin Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epigenetic regulation espeically histone modifications in breast cancer: A viable and emerging targeted therapeutic strategy 2025 ·Journal of Cancer ·Yibing Zhou, Haotian Liu, Weimin Hong, HaiFeng Su, (unknown), (unknown), (unknown), (unknown), Da Qian	0
2	Preclinical Profile of CM699 as a Medication Candidate for Stimulant Use Disorder 2025 ·ACS Chemical Neuroscience ·Takato Hiranita, Weimin Hong, Abhisheak Sharma, (unknown), Christophe Mésangeau, (unknown), (unknown), Theresa Kopajtic, (unknown), Bonnie A. Avery, Gianluigi Tanda, Christopher R. McCurdy, Jonathan L. Katz	0
3	Pachymic acid alleviates secondary lymphedema through the modulation of EETs level and the inhibition of lymphatic fibrosis 2025 ·International Immunopharmacology ·Xiang Fang, Tingting Xiao, Yongfeng Li, (unknown), (unknown), Weimin Hong, (unknown), Danhong Wang, Xuli Meng, (unknown)	0
4	Evaluating white matter alterations in Parkinson’s disease-related parkin S/N167 mutation carriers using tract-based spatial statistics 2022 ·Quantitative Imaging in Medicine and Surgery ·(unknown), Lina Chen, Guoen Cai, Ying-Qing Wang, Xiaochun Chen, Weimin Hong, Qinyong Ye	4
5	Distinct Regulation of σ1 Receptor Multimerization by Its Agonists and Antagonists in Transfected Cells and Rat Liver Membranes 2020 ·Journal of Pharmacology and Experimental Therapeutics ·Weimin Hong	16
6	Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays 2018 ·Neuropharmacology ·Hideaki Yano, Alessandro Bonifazi, (unknown), Daryl A. Guthrie, (unknown), Ara M. Abramyan, (unknown), Weimin Hong, Amy Hauck Newman, Lei Shi	51
7	Dopamine Transporter Dynamics of N-Substituted Benztropine Analogs with Atypical Behavioral Effects 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Weimin Hong, (unknown), Derek S. Wilkinson, Takato Hiranita, Libin Li, Shuichiro Hayashi, (unknown), Jeffry D. Madura, Christopher K. Surratt, Jonathan L. Katz	5
8	σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Takato Hiranita, Weimin Hong, Theresa Kopajtic, Jonathan L. Katz	11
9	The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats 2017 ·Journal of Biological Chemistry ·Weimin Hong, Hideaki Yano, Takato Hiranita, Frederick T. Chin, Christopher R. McCurdy, Tsung‐Ping Su, Susan Amara, Jonathan L. Katz	61
10	2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Weimin Hong, (unknown), Liang Xu, (unknown), (unknown), Jeffry D. Madura, Christopher K. Surratt, Mark L. Trudell, Jonathan L. Katz	12
11	A role for sigma receptors in stimulant self-administration and addiction 2015 ·Behavioural Pharmacology ·Jonathan L. Katz, Weimin Hong, Takato Hiranita, Tsung‐Ping Su	31
12	Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter 2014 ·Drug and Alcohol Dependence ·Maarten E. A. Reith, Bruce E. Blough, Weimin Hong, Kymry T. Jones, Kyle C. Schmitt, Michael H. Baumann, John S. Partilla, Richard B. Rothman, Jonathan L. Katz	108
13	2-Isoxazol-3-Phenyltropane Derivatives of Cocaine: Molecular and Atypical System Effects at the Dopamine Transporter 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Takato Hiranita, Derek S. Wilkinson, Weimin Hong, Mu‐Fa Zou, Theresa Kopajtic, Paul L. Soto, Carl R. Lupica, Amy Hauck Newman, Jonathan L. Katz	25
14	Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine‐ or PKC‐regulated endocytosis in dopamine neurons 2013 ·The FASEB Journal ·Weimin Hong, Susan Amara	55
15	Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake 2011 ·International Journal of Biological Sciences ·Hongxia Zhou, Cao Huang, Jianbin Tong, Weimin Hong, Yongjian Liu, Xu‐Gang Xia	48
16	Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding 2010 ·Journal of Biological Chemistry ·Weimin Hong, Susan Amara	122
17	Modulation of bradykinin‐induced calcium changes in SH‐SY5Y cells by neurosteroids and sigma receptor ligands via a shared mechanism 2004 ·Synapse ·Weimin Hong, (unknown), Linda L. Werling	36
18	Binding of σ receptor ligands and their effects on muscarine-induced Ca2+ changes in SH-SY5Y cells 2002 ·European Journal of Pharmacology ·Weimin Hong, Linda L. Werling	12
19	Lack of effects by σ ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum 2001 ·Brain Research ·Weimin Hong, Linda L. Werling	9
20	Evidence that the σ1 receptor is not directly coupled to G proteins 2000 ·European Journal of Pharmacology ·Weimin Hong, Linda L. Werling	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact